Updated Jul 16, 2026
Murphy Nicole is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $585.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | BIIB | BIOGEN INC. | P — Open-market purchase | 3 | $195.03 | $585 |
| 2026-02-10 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 1.4K | $201.18 | $283K |
| 2026-02-10 | BIIB | BIOGEN INC. | M — Option exercise | 4.7K | $0.00 | |
| 2026-02-10 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 914 | $201.18 | $184K |
| 2026-02-10 | BIIB | BIOGEN INC. | M — Option exercise | 1.9K | $0.00 | |
| 2026-02-10 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 1.0K | $201.18 | $205K |
| 2026-02-10 | BIIB | BIOGEN INC. | M — Option exercise | 2.1K | $0.00 |
Murphy Nicole is a corporate insider — currently tracked as Head of Pharm Ops and Tech. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($585) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Murphy Nicole profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.